Congenital nystagmus (CN) is characterized by conjugated, spontaneous, and involuntary ocular oscillations. It is an inherited disease and the most common inheritance pattern is X-linked CN. Four-point-one, ezrin, radixin, moesin domain-containing 7 (*FRMD7*) and G protein-coupled receptor 143 (*GPR143*) have been identified as the disease-causing genes for X-linked CN.\[[@ref1][@ref2]\] The *FRMD7* gene comprises 12 exons and encodes a protein with 714 amino acids. The *GPR143* gene consists of 9 exons and encodes a protein with 404 amino acids.

Numerous mutations in *FRMD7* gene have been reported since it was first identified in 2006.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] Mutations in *FRMD7* gene are the major causes of Chinese familial X-linked CN and account for approximately 47% of Chinese patients with the disorder.\[[@ref9]\]

*GPR143* gene is also known as the ocular albinism type 1 (*OA1*) gene, as mutations in *GPR143* also cause OA1.\[[@ref10]\] Most patients with OA1 show nystagmus and poor visual acuity. Several reports confirmed the pathogenicity of *GPR143* gene in CN family.\[[@ref2][@ref11][@ref12][@ref13][@ref14]\]

In this study, we analyzed the variants in *FRMD7* and *GPR143* genes in a sixth-generation, nonconsanguineous CN Chinese family. We identified a deletion covering 3--9 exons of *GPR143* gene resulting in a truncated protein of 120 residues. Our results expand the spectrum of *GPR143* mutations causing CN. This is the first report of molecular characterization in the *GPR143* gene in the CN family.

Methods {#sec1-1}
=======

A sixth-generation Han family from Hebei Province in China including six male patients participated in this study \[[Fig. 1](#F1){ref-type="fig"}\]. The patients underwent complete physical and ophthalmic examinations. The Institutional Review Board approved the project, and investigators followed the principles of the Declaration of Helsinki. Informed consent was obtained from each person. One hundred normal male controls mainly from the north of China were also analyzed.

![The pedigree of family. Squares and circles indicate males and females, the darkened symbols represent affected members, dot-marked symbols represent females who carried the mutation, and the patient above the arrow is the proband](IJO-64-813-g001){#F1}

Blood specimens (8 ml) of each family member available were collected in ethylenediaminetetraacetic acid, and genomic DNA was extracted from peripheral blood cells according to a standard protocol (Roche Diagnostics Corporation, Indianapolis, IN, USA). In brief, all the exons and exon-intron boundaries of *FRMD7* and *GPR143* genes were amplified using the standard polymerase chain reaction (PCR) buffer system with primers listed in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. PCR reactions were performed in a 10 μL volume, containing 1.5 mM MgCl2, 0.4 mM of each primer, 200 μM dNTPs, 1 U Taq DNA polymerase, and 10--20 ng template DNA. Amplification was performed with an initial denaturation for 3 min at 95°C, followed by 30 cycles of denaturation at 95°C for 1 min, annealing at 55°C for 1 min, extension at 72°C for 1 min, and a final extension at 72°C for 3 min. PCR products were purified using a PCR product purification kit (QIAquick; Qiagen, Valencia, CA, USA). The purified PCR products were sequenced using the BigDye Terminator Cycle Sequencing v3.1 kit (Applied Biosystems, Foster City, CA, USA). Briefly, about 10 ng of template DNA was added in each reaction using a temperature program which included 25 cycles of denaturation at 95°C for 30 s, annealing at 50°C for 15 s, and extension at 60°C for 4 min. All samples were analyzed in an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). The *FRMD7* and *GPR143* cDNA reference sequence with GenBank accession was used (National Center for Biotechnical Information, Bethesda, Md; available at: <http://www.ncbi.nlm.nih.gov>).

###### 

Primers used to amplify the exons of four-point-one, ezrin, radixin, moesin domain-containing 7
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###### 

Primers used to amplify the exons of G protein-coupled receptor 143

![](IJO-64-813-g003)

Results {#sec1-2}
=======

This sixth-generation pedigree showed a high possibility of an X-linked recessive inheritance pattern \[[Fig. 1](#F1){ref-type="fig"}\]. All patients in this family had various reduced visual acuity with a similar pattern of nystagmus. The type of nystagmus in the family appeared to be jerk nystagmus that manifests as early as at birth. They all had reduced vision, amblyopia, and astigmatism at a different degree. There were normal pigmentation of skin and hair in all patients. Moreover, no retinal pathological changes, optic nerve lesions, any typical sign of OA1, and hypopigmentation of the iris and fundus were detected \[Figs. [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"} and [Table 3](#T3){ref-type="table"}\].

![The iris of proband (VI1) in family, (a) right eye, (b) left eye](IJO-64-813-g004){#F2}

![Photographs of fundus from proband (VI1) in family, (a) right eye, (b) left eye](IJO-64-813-g005){#F3}

![Photographs of OCT from proband (VI1) in family, (a) right eye, (b) left eye](IJO-64-813-g006){#F4}

###### 

Summary of clinical features of some affected males and carriers

![](IJO-64-813-g007)

We sequenced 12 coding exons of *FRMD7*, 9 coding exons of *GPR143*, and the adjacent intronic regions of these two genes in the patients. After a complete analysis of the coding sequence of *FRMD7* and *GPR143*, there was no mutation in *FRMD7* and no PCR products for the DNA fragments spanning exon 3 to exon 9 of *GPR143*, suggesting a large deletion in this region \[[Fig. 5](#F5){ref-type="fig"}\].

![The polymerase chain reaction results of GPR143 gene. M: marker; E1--E9: exon1--Exon9; C: Represents carrier member; P: Represents affected member](IJO-64-813-g008){#F5}

The mutation was detected in all patients but not found in other unaffected members or in the 100 normal controls. It was predicted to result in a premature stop codon emerged in exon 2, resulting in a truncated protein of only 120 amino acids.

Discussion {#sec1-3}
==========

Bassi *et al*. cloned *GPR143* gene for OA1 on chromosome Xp22.3.\[[@ref15]\] Schiaffino *et al*. detected various mutations in *GPR143* in one-third of X-linked ocular albinism.\[[@ref10]\] Sometimes, OA1 can be ignored or misdiagnosed, the ocular disorders should be eliminated before the diagnosis of congenital motor nystagmus is made. X-linked OA1 is characterized by decreased ocular pigmentation, foveal hypoplasia, nystagmus, photodysphoria, and reduced visual acuity. All patients in this family had various reduced visual acuity with nystagmus but there were no retinal pathological changes, optic nerve lesions, or any typical sign of OA1.

We have characterized nystagmus in a sixth-generation Chinese family with a X-linked recessive inheritance pattern. No mutation was identified in the *FRMD7* gene and a novel large deletion in exon 3 to exon 9 of the *GPR143* gene. All the affected males were hemizygous for the mutation and female carriers were heterozygous for the mutation whereas other normal members of the family had no mutation. These results strongly suggested that the 3--9 exons deletion of *GPR143* gene causes the disease in the family.

Until now, more than 100 mutations of *GPR143* have been determined, including frameshift deletion and nonsense mutations. Most mutations were reported to cause ocular albinism, but some mutations were reported to cause CN without classical phenotype of ocular albinism.\[[@ref12][@ref13]\]

The human *GPR143* gene consists of 9 exons which encode a 439-kDa protein of 404 amino acids with homology to seven transmembrane segments, a GPR. The GPR has been shown to participate in the most common signal transduction system at the plasma membrane. Thus, it suggests that *GPR143* mediates signal transduction system and operates at the internal membranes in mammalian cells.\[[@ref16]\] Giordano used siRNA inactivation of *GPR143* and combined morphological and biochemical methods to investigate melanosomal ultrastructure, melanosomal protein localization, and expression in human pigmented melanocytic cells. The functional loss of *GPR143* may lead to decreased pigmentation and causes formation of enlarged aberrant premelanosomes harboring disorganized fibrillar structures and displays proteins of mature melanosomes and lysosomes at their membrane.\[[@ref17]\]

We revealed the 7-exons deletion of *GPR143* in a Chinese pedigree. The presence of the deletion in all patients and its absence in unaffected members and other 100 unrelated controls indicate that the identified deletion causes CN. The deletion in *GPR143* is predicted to result in a truncated protein of 120 amino acid residues, in which the C-terminus of *GPR143* protein was deleted.

Conclusions {#sec1-4}
===========

Our results expand the spectrum of *GPR143* mutations causing CN and also confirm the role of *GPR143* in the pathogenesis of CN.
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